Literature DB >> 21579110

3-[2-(3-Methyl-quinoxalin-2-yl-oxy)eth-yl]-1,3-oxazolidin-2-one.

Caleb Anothane Ahoya, Rachid Bouhfid, Ballo Daouda, El Mokhtar Essassi, Lahcen El Ammari.   

Abstract

Two isomers were isolated during the reaction between 3-methyl-quinoxalin-2-one and bis-(2-chloro-ethyl)amine hydro-chloride. The crystal structure of one isomer has already been reported [Caleb, Bouhfid, Essassi & El Ammari (2009). Acta Cryst. E65, o2024-o2025], while that of the second isomer is the subject of this work. The title compound, C(14)H(15)N(3)O(3), has a new structure containing oxazolidine and quinoxaline rings linked by an eth-oxy group. The main difference between the two isomers is the position of the oxazolidine group with respect to the quinoxaline system. The dihedral angle between the fused planar rings and the oxazolidin-2-one ring is 41.63 (8)° in the title mol-ecule.

Entities:  

Year:  2010        PMID: 21579110      PMCID: PMC2979098          DOI: 10.1107/S1600536810012687

Source DB:  PubMed          Journal:  Acta Crystallogr Sect E Struct Rep Online        ISSN: 1600-5368


Related literature

For the biological activity of 3-[2-(3-methyl-1,2-dihydro­quin­oxalin-2-yl­oxy)eth­yl]oxazolidin-2-one, see: Madhusudhan et al. (2004 ▶); Soad et al. (2006 ▶); Sriharsha & Shashikanth (2006 ▶); Menoret et al. (2009 ▶); Wilhelmsson et al. (2008 ▶). For the structure of the isomer of the title compound, see: Caleb et al. (2009 ▶). For related structures, see: Doubia et al. (2007 ▶); Mamedov et al. (2007 ▶); Aschwanden et al.(1976 ▶)

Experimental

Crystal data

C14H15N3O3 M = 273.29 Triclinic, a = 6.9936 (3) Å b = 7.6916 (3) Å c = 13.3709 (6) Å α = 86.649 (2)° β = 77.044 (2)° γ = 71.141 (2)° V = 663.23 (5) Å3 Z = 2 Mo Kα radiation μ = 0.10 mm−1 T = 296 K 0.41 × 0.33 × 0.20 mm

Data collection

Bruker X8 APEXII CCD area-detector diffractometer 15358 measured reflections 3030 independent reflections 2358 reflections with I > 2σ(I) R int = 0.023

Refinement

R[F 2 > 2σ(F 2)] = 0.040 wR(F 2) = 0.121 S = 1.06 3030 reflections 198 parameters H atoms treated by a mixture of independent and constrained refinement Δρmax = 0.21 e Å−3 Δρmin = −0.17 e Å−3 Data collection: APEX2 (Bruker, 2005 ▶); cell refinement: APEX2; data reduction: APEX2; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008 ▶); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008 ▶); molecular graphics: ORTEP-3 for Windows (Farrugia,1997 ▶) and PLATON (Spek, 2009 ▶); software used to prepare material for publication: WinGX (Farrugia, 1999 ▶). Crystal structure: contains datablocks global, I. DOI: 10.1107/S1600536810012687/dn2552sup1.cif Structure factors: contains datablocks I. DOI: 10.1107/S1600536810012687/dn2552Isup2.hkl Additional supplementary materials: crystallographic information; 3D view; checkCIF report
C14H15N3O3Z = 2
Mr = 273.29F(000) = 288
Triclinic, P1Dx = 1.368 Mg m3
Hall symbol: -P 1Mo Kα radiation, λ = 0.71073 Å
a = 6.9936 (3) ÅCell parameters from 15358 reflections
b = 7.6916 (3) Åθ = 2.8–27.5°
c = 13.3709 (6) ŵ = 0.10 mm1
α = 86.649 (2)°T = 296 K
β = 77.044 (2)°Prism, colourless
γ = 71.141 (2)°0.41 × 0.33 × 0.20 mm
V = 663.23 (5) Å3
Bruker X8 APEXII CCD area-detector diffractometer2358 reflections with I > 2σ(I)
Radiation source: fine-focus sealed tubeRint = 0.023
graphiteθmax = 27.5°, θmin = 2.8°
φ and ω scansh = −9→9
15358 measured reflectionsk = −9→9
3030 independent reflectionsl = −17→17
Refinement on F2Primary atom site location: structure-invariant direct methods
Least-squares matrix: fullSecondary atom site location: difference Fourier map
R[F2 > 2σ(F2)] = 0.040Hydrogen site location: inferred from neighbouring sites
wR(F2) = 0.121H atoms treated by a mixture of independent and constrained refinement
S = 1.06w = 1/[σ2(Fo2) + (0.0643P)2 + 0.0716P] where P = (Fo2 + 2Fc2)/3
3030 reflections(Δ/σ)max < 0.001
198 parametersΔρmax = 0.21 e Å3
0 restraintsΔρmin = −0.17 e Å3
Geometry. All esds (except the esd in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell esds are taken into account individually in the estimation of esds in distances, angles and torsion angles; correlations between esds in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell esds is used for estimating esds involving l.s. planes.
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger.
xyzUiso*/Ueq
C10.31122 (17)0.72867 (15)0.95763 (8)0.0378 (3)
C20.08813 (17)0.80823 (15)1.11146 (8)0.0382 (3)
C3−0.11007 (19)0.83829 (18)1.17492 (10)0.0470 (3)
C4−0.1442 (2)0.8837 (2)1.27638 (10)0.0531 (3)
C50.0143 (2)0.90272 (19)1.31801 (10)0.0540 (3)
C60.2068 (2)0.87655 (18)1.25750 (10)0.0503 (3)
C70.24799 (18)0.82807 (16)1.15335 (9)0.0403 (3)
C80.47691 (17)0.75240 (16)0.99773 (9)0.0412 (3)
C90.68526 (19)0.7217 (2)0.92895 (11)0.0546 (3)
H9A0.73710.59870.90150.082*
H9B0.77840.73930.96740.082*
H9C0.67430.80750.87370.082*
C100.21267 (19)0.63937 (19)0.81444 (9)0.0465 (3)
H10A0.11050.75510.80410.056*
H10B0.14290.56430.85930.056*
C110.3226 (2)0.54186 (19)0.71328 (10)0.0523 (3)
H11A0.42180.42580.72580.063*
H11B0.22210.51460.68260.063*
C120.3726 (3)0.7066 (2)0.55269 (11)0.0625 (4)
C130.6852 (3)0.7454 (3)0.54185 (14)0.0820 (5)
H13A0.69570.86340.55700.098*
H13B0.81510.67390.49860.098*
C140.6363 (3)0.6450 (3)0.63974 (11)0.0682 (4)
H14A0.73190.52090.63750.082*
H14B0.63940.70980.69910.082*
N10.12438 (14)0.75658 (13)1.01023 (7)0.0406 (2)
N20.44386 (15)0.80020 (15)1.09343 (8)0.0462 (3)
N30.43028 (18)0.64507 (16)0.64066 (8)0.0534 (3)
O10.36793 (12)0.67107 (12)0.85906 (6)0.0460 (2)
O20.2172 (2)0.70974 (18)0.52691 (9)0.0879 (4)
O30.5186 (2)0.76983 (16)0.49204 (8)0.0829 (4)
H3−0.220 (2)0.8300 (19)1.1449 (11)0.052 (4)*
H4−0.280 (2)0.908 (2)1.3175 (13)0.068 (4)*
H5−0.009 (2)0.934 (2)1.3883 (14)0.064 (4)*
H60.322 (3)0.889 (2)1.2864 (13)0.071 (4)*
U11U22U33U12U13U23
C10.0389 (6)0.0433 (6)0.0313 (6)−0.0140 (5)−0.0066 (4)0.0011 (4)
C20.0413 (6)0.0410 (6)0.0317 (6)−0.0135 (5)−0.0066 (4)0.0011 (4)
C30.0439 (7)0.0559 (7)0.0406 (7)−0.0189 (6)−0.0031 (5)−0.0016 (5)
C40.0526 (7)0.0592 (8)0.0396 (7)−0.0161 (6)0.0039 (6)−0.0019 (6)
C50.0656 (8)0.0568 (8)0.0317 (7)−0.0106 (6)−0.0064 (6)−0.0048 (5)
C60.0545 (8)0.0564 (8)0.0388 (7)−0.0113 (6)−0.0162 (6)−0.0043 (5)
C70.0415 (6)0.0427 (6)0.0354 (6)−0.0106 (5)−0.0097 (5)−0.0003 (5)
C80.0366 (6)0.0476 (6)0.0391 (6)−0.0127 (5)−0.0083 (5)−0.0005 (5)
C90.0394 (6)0.0745 (9)0.0505 (8)−0.0210 (6)−0.0050 (5)−0.0066 (6)
C100.0446 (6)0.0629 (8)0.0351 (6)−0.0211 (6)−0.0079 (5)−0.0038 (5)
C110.0608 (8)0.0600 (8)0.0381 (7)−0.0217 (6)−0.0093 (6)−0.0066 (5)
C120.0842 (11)0.0549 (8)0.0358 (7)−0.0028 (8)−0.0139 (7)−0.0097 (6)
C130.0972 (13)0.0874 (12)0.0545 (10)−0.0363 (10)0.0076 (9)0.0021 (8)
C140.0723 (10)0.0929 (11)0.0440 (8)−0.0373 (9)−0.0061 (7)0.0036 (7)
N10.0385 (5)0.0515 (6)0.0331 (5)−0.0169 (4)−0.0062 (4)−0.0017 (4)
N20.0400 (5)0.0571 (6)0.0425 (6)−0.0140 (5)−0.0120 (4)−0.0036 (5)
N30.0602 (7)0.0644 (7)0.0316 (5)−0.0157 (5)−0.0071 (5)−0.0024 (5)
O10.0409 (4)0.0667 (6)0.0316 (4)−0.0203 (4)−0.0035 (3)−0.0063 (4)
O20.1019 (9)0.0914 (9)0.0633 (8)−0.0034 (7)−0.0421 (7)−0.0077 (6)
O30.1211 (10)0.0797 (8)0.0399 (6)−0.0288 (7)−0.0081 (6)0.0096 (5)
C1—N11.2932 (14)C9—H9C0.9600
C1—O11.3457 (13)C10—O11.4398 (13)
C1—C81.4458 (15)C10—C111.5041 (18)
C2—N11.3777 (14)C10—H10A0.9700
C2—C31.4083 (16)C10—H10B0.9700
C2—C71.4099 (15)C11—N31.4523 (17)
C3—C41.3695 (18)C11—H11A0.9700
C3—H30.966 (14)C11—H11B0.9700
C4—C51.397 (2)C12—O21.2046 (19)
C4—H40.949 (16)C12—N31.3394 (19)
C5—C61.3646 (19)C12—O31.357 (2)
C5—H50.948 (17)C13—O31.424 (2)
C6—C71.4045 (17)C13—C141.510 (2)
C6—H60.999 (17)C13—H13A0.9700
C7—N21.3793 (15)C13—H13B0.9700
C8—N21.3013 (15)C14—N31.4379 (19)
C8—C91.4923 (16)C14—H14A0.9700
C9—H9A0.9600C14—H14B0.9700
C9—H9B0.9600
N1—C1—O1121.60 (10)C11—C10—H10A110.3
N1—C1—C8124.34 (10)O1—C10—H10B110.3
O1—C1—C8114.06 (9)C11—C10—H10B110.3
N1—C2—C3119.79 (10)H10A—C10—H10B108.6
N1—C2—C7120.95 (10)N3—C11—C10114.20 (11)
C3—C2—C7119.25 (11)N3—C11—H11A108.7
C4—C3—C2119.75 (12)C10—C11—H11A108.7
C4—C3—H3121.5 (9)N3—C11—H11B108.7
C2—C3—H3118.7 (8)C10—C11—H11B108.7
C3—C4—C5121.01 (12)H11A—C11—H11B107.6
C3—C4—H4118.6 (10)O2—C12—N3127.96 (16)
C5—C4—H4120.3 (10)O2—C12—O3122.31 (14)
C6—C5—C4120.14 (12)N3—C12—O3109.73 (14)
C6—C5—H5118.9 (9)O3—C13—C14106.05 (14)
C4—C5—H5120.9 (9)O3—C13—H13A110.5
C5—C6—C7120.42 (12)C14—C13—H13A110.5
C5—C6—H6120.9 (10)O3—C13—H13B110.5
C7—C6—H6118.6 (10)C14—C13—H13B110.5
N2—C7—C6119.74 (10)H13A—C13—H13B108.7
N2—C7—C2120.85 (10)N3—C14—C13101.80 (14)
C6—C7—C2119.41 (11)N3—C14—H14A111.4
N2—C8—C1119.95 (10)C13—C14—H14A111.4
N2—C8—C9120.35 (10)N3—C14—H14B111.4
C1—C8—C9119.70 (11)C13—C14—H14B111.4
C8—C9—H9A109.5H14A—C14—H14B109.3
C8—C9—H9B109.5C1—N1—C2115.96 (9)
H9A—C9—H9B109.5C8—N2—C7117.92 (10)
C8—C9—H9C109.5C12—N3—C14112.13 (13)
H9A—C9—H9C109.5C12—N3—C11122.09 (13)
H9B—C9—H9C109.5C14—N3—C11123.42 (12)
O1—C10—C11106.91 (10)C1—O1—C10117.34 (9)
O1—C10—H10A110.3C12—O3—C13109.59 (12)
  7 in total

1.  Synthesis and in vitro-anticancer and antimicrobial evaluation of some novel quinoxalines derived from 3-phenylquinoxaline-2(1H)-thione.

Authors:  Soad A M El-Hawash; Abeer E Abdel Wahab
Journal:  Arch Pharm (Weinheim)       Date:  2006-08       Impact factor: 3.751

2.  A short history of SHELX.

Authors:  George M Sheldrick
Journal:  Acta Crystallogr A       Date:  2007-12-21       Impact factor: 2.290

3.  [Stereospecifity of the neuroleptic activity and chirality of (+)-3-(2-(4-(8-fluoro-2-methyl-10, 11-dihydrodibenzo(b, f)thiepin-10-yl)-1-piperazinyl)ethyl)-2-oxazolidinone (author's transl)].

Authors:  W Aschwanden; E Kyburz; P Schönholzer
Journal:  Helv Chim Acta       Date:  1976       Impact factor: 2.164

4.  Interactions of antiviral indolo[2,3-b]quinoxaline derivatives with DNA.

Authors:  L Marcus Wilhelmsson; Ngarita Kingi; Jan Bergman
Journal:  J Med Chem       Date:  2008-12-25       Impact factor: 7.446

5.  The oxazolidinone derivative locostatin induces cytokine appeasement.

Authors:  Antoine Ménoret; Jeremy P McAleer; Soo-Mun Ngoi; Swagatam Ray; Nicholas A Eddy; Gabriel Fenteany; Seung-Joo Lee; Robert J Rossi; Bijay Mukherji; David L Allen; Nitya G Chakraborty; Anthony T Vella
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

6.  3-[2-(3-Methyl-2-oxo-1,2-dihydro-quinoxalin-1-yl)eth-yl]oxazolidin-2-one.

Authors:  Ahoya Anothane Caleb; Rachid Bouhfid; El Mokhtar Essassi; Lahcen El Ammari
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-07-29

7.  Structure validation in chemical crystallography.

Authors:  Anthony L Spek
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2009-01-20
  7 in total
  3 in total

1.  1,3-Bis[2-(2-oxo-1,3-oxazolidin-3-yl)eth-yl]-1H-benzimidazol-2(3H)-one.

Authors:  Younes Ouzidan; Youssef Kandri Rodi; Frank R Fronczek; Ramaiyer Venkatraman; Lahcen El Ammari; El Mokhtar Essassi
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-01-12

2.  3-{2-[(3-Phenyl-quinoxalin-2-yl)-oxy]ethyl}-1,3-oxazolidin-2-one.

Authors:  Ballo Daouda; Lydia Brelot; Mouhamadou Lamine Doumbia; El Mokhtar Essassi; Seik Weng Ng
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2011-04-29

3.  3-[2-(1H-Benzimidazol-2-ylsulfan-yl)eth-yl]-1,3-oxazolidin-2-one.

Authors:  Ahmed Moussaif; El Mokhtar Essassi; Said Lazar; Hafid Zouihri; Jean Michel Leger
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2010-11-13
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.